Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes: A systematic review
Open Access
- 1 December 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 12, 1075201
Abstract
There is a strong link between fecal microbiota and the development of type 1 diabetes. As an emerging therapeutic modality, fecal microbiota transplantation has been shown to be safe and effective in the treatment of many intestinal and extraintestinal diseases. Various studies have found that fecal microbiota transplantation can treat diseases by correcting patients’ immune disorders. Besides, many studies have found that fecal microbiota transplantation can improve glycemic control and insulin resistance in diabetic patients. Therefore, this paper reviews the mechanism of action of fecal microbiota transplantation on autoimmune-mediated T1DM and the current research progress, feasibility, and issues that need to be addressed in the future development of fecal microbiota transplantation in the treatment of autoimmune-mediated T1DM.Keywords
This publication has 117 references indexed in Scilit:
- The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43Nature Communications, 2013
- Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control studyBMC Medicine, 2013
- An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree miceThe ISME Journal, 2012
- NLRC4-driven production of IL-1β discriminates between pathogenic and commensal bacteria and promotes host intestinal defenseNature Immunology, 2012
- Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2Diabetes, 2012
- Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 DiabetesPLOS ONE, 2011
- Toward defining the autoimmune microbiome for type 1 diabetesThe ISME Journal, 2010
- Prediction and Pathogenesis in Type 1 DiabetesImmunity, 2010
- Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41Proceedings of the National Academy of Sciences, 2008
- Metabolic Endotoxemia Initiates Obesity and Insulin ResistanceDiabetes, 2007